Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)

Immunochemical quantitation of antigens by single radial immunodiffusion

1965 • 9,369 citations

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1955 • 8,846 citations

Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

1963 • 2,254 citations

Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease

1971 • 2,055 citations

Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience

1961 • 1,758 citations

Correlation of Glucose Regulation and Hemoglobin A_Icin Diabetes Mellitus

1976 • 1,159 citations

Regulation of Plasma Cholesterol by Lipoprotein Receptors

1981 • 958 citations

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

1983 • 562 citations

Epidemiology of Diabetes and Its Vascular Lesions.

1979 • 559 citations

Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol

1973 • 442 citations

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.

1981 • 424 citations

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1986 • 376 citations

Application of a New Peroxide Indicator Reaction to the Specific, Automated Determination of Glucose with Glucose Oxidase

1972 • 291 citations

Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

1984 • 266 citations

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

1985 • 210 citations

Hyperglycemia and Plasma Lipid Levels

1980 • 196 citations

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

1987 • 196 citations

Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes Mellitus

1988 • 158 citations

Arteriosclerotic heart disease in diabetes mellitus

1955 • 95 citations

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism

1984 • 93 citations

Complications of Diabetes

1976 • 91 citations

Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

1983 • 81 citations

The Effect of CS-514 on Serum Lipids and Apolipoproteins in Hypercholesterolemic Subjects

1987 • 79 citations

Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects

1979 • 76 citations

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia

1987 • 54 citations

Quantitation of apolipoprotein A-I in pooled human serum by single radial immunodiffusion and sodium dodecyl sulfate-polyacrylamide gel electrophoresis

1984 • 50 citations

The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy Volunteers

1986 • 49 citations

Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats

1988 • 40 citations

Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects

1988 • 24 citations

Effect of CS-514, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on lipoprotein and apolipoprotein in plasma of hypercholesterolemic diabetics

1986 • 23 citations

The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects

1987 • 18 citations

Effects of CS-514, a New Inhibitor of HMG CoA Reductase, on Plasma Lipids, Lipoproteins and Apoproteins in Patients with Primary Hypercholesterolemia

1986 • 17 citations

Plasma apolipoprotein CII levels in hypertriglyceridemia

1986 • 12 citations

CS-514 Suppresses Plasma Triglyceride in Hypertriglyceridemic Subjects Without Modifying a Lipoprotein Structural Model

1987 • 11 citations